Publicaciones (59) Publicaciones en las que ha participado algún/a investigador/a

2001

  1. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

    Psychopharmacology, Vol. 154, Núm. 3, pp. 251-260

  2. 3-D-QSAR/CoMFA and recognition models of benzimidazole derivatives at the 5-HT(4) receptor

    Bioorganic and medicinal chemistry letters, Vol. 11, Núm. 21, pp. 2807-2811

  3. A neurotoxic dose of 3, 4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long term defect in thermoregulation

    Psychopharmacology, Vol. 155, Núm. 4, pp. 413-418

  4. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain

    British Journal of Pharmacology, Vol. 134, Núm. 8, pp. 1711-1723

  5. Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat

    Hepatology, Vol. 34, Núm. 6, pp. 1164-1173

  6. Adenosine triphosphate and diadenosine pentaphosphate induce [Ca2+]i increase in rat basal ganglia aminergic terminals

    Journal of Neuroscience Research, Vol. 64, Núm. 2, pp. 174-182

  7. African swine fever virus protein p54 interacts with the microtubular motor complex through direct binding to light-chain dynein

    Journal of Virology, Vol. 75, Núm. 20, pp. 9819-9827

  8. An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors

    European Journal of Neuroscience, Vol. 13, Núm. 8, pp. 1469-1478

  9. Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

    Journal of Neurochemistry, Vol. 78, Núm. 6, pp. 1415-1427

  10. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist

    Pharmacology, Vol. 62, Núm. 4, pp. 234-242

  11. Calcium channel types involved in intrinsic amino acid neurotransmitters release evoked by depolarizing agents in cortical neurons

    Neurochemistry International, Vol. 39, Núm. 4, pp. 283-290

  12. Cardiac effects of diinosine tetraphosphate, a putative dinucleotide receptor antagonist

    Drug Development Research, Vol. 52, Núm. 3, pp. 500-503

  13. Ceramide: A new second messenger of cannabinoid action

    Trends in Pharmacological Sciences, Vol. 22, Núm. 1, pp. 19-22

  14. Changes in cannabinoid CB1 receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis

    Synapse, Vol. 41, Núm. 3, pp. 195-202

  15. Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease

    NeuroReport, Vol. 12, Núm. 10, pp. 2125-2129

  16. Chemical mechanism of β-xylosidase from Trichoderma reesei QM 9414: pH-dependence of kinetic parameters

    Biochimie, Vol. 83, Núm. 10, pp. 961-967

  17. Cloning, expression, and purification of Histidine-tagged preS domains of hepatitis B virus

    Protein Expression and Purification, Vol. 21, Núm. 1, pp. 183-191

  18. Computational model of the complex between GR113808 and the 5-HT4 receptor guided by site-directed mutagenesis and the crystal structure of rhodopsin

    Journal of Computer-Aided Molecular Design, Vol. 15, Núm. 11, pp. 1025-1033

  19. Control of the cell survival/death decision by cannabinoids

    Journal of Molecular Medicine, Vol. 78, Núm. 11, pp. 613-625

  20. Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors

    Journal of Medicinal Chemistry, Vol. 44, Núm. 26, pp. 4505-4508